Asian Journal of Transfusion Science
Home About Journal Editorial Board Search Current Issue Ahead of print Back Issues Instructions Subscribe Login  Users: 145 Print this page  Email this page Small font sizeDefault font sizeIncrease font size 


 
ORIGINAL ARTICLE Table of Contents   
Year : 2017  |  Volume : 11  |  Issue : 2  |  Page : 188-191
The prozone effect exerted by the complement-binding anti-Lea on anti-D


1 Director, Lok Samarpan Raktadan Kendra, Surat, Gujarat, India
2 Department of Neonatology, Amruta Hospital, Surat, Gujarat, India

Click here for correspondence address and email

Date of Submission12-Aug-2016
Date of Acceptance24-Dec-2016
Date of Web Publication11-Sep-2017
 

   Abstract 

Background: Prozone phenomenon is seen with very high-titer antibodies in an immune serum.
Aim: The prozone effect on anti-D by a low-titer anti-Lea was investigated associated with neonatal jaundice.
Materials and Methods: Standard methods were used in investigations.
Results: The child was born at full-term developed mild jaundice. With weak direct antiglobulin test+, her indirect serum bilirubin was progressed to 27.5 mg/dL in 48 h. Anti-D and anti-Lea were detected in the mother. Both these antibodies were detected in the child's serum though the eluate from red blood cells (RBCs) contained only anti-D. Mother's anti-D was masked by anti-Lea if the RBCs possessed both the antigens together. Anti-D was revealed only with D-positive RBCs lacking Lea or if the serum was modified by mixing with Lea+ saliva or was heated at 56°C or fortified with citrate solution.
Conclusion: An anti-D showed prozone effect exerted by the complement-fixing anti-Lea in the test.

Keywords: anti-D, anti-Lewis, complement-mediated inhibition, prozone

How to cite this article:
Joshi SR, Parekh KH. The prozone effect exerted by the complement-binding anti-Lea on anti-D. Asian J Transfus Sci 2017;11:188-91

How to cite this URL:
Joshi SR, Parekh KH. The prozone effect exerted by the complement-binding anti-Lea on anti-D. Asian J Transfus Sci [serial online] 2017 [cited 2017 Sep 21];11:188-91. Available from: http://www.ajts.org/text.asp?2017/11/2/188/214328



   Introduction Top


The prozone phenomenon, described as masking of serological reaction in undiluted serum but increased strength of reaction upon its dilution, is characteristically associated with certain hyperimmune anti-Rh and antiglobulin sera.[1] It is due to an excess of antibody molecules in the serum blocks the most antigenic sites in such a way that prevents cross-linking of the red blood cells (RBCs). However, the prozone effect occasionally observed with respect to a high-titer ABO antibodies was thought to be due to a steric hindrance created by the complement molecules fixed on the cell surface following antigen–antibody complex formation.[2] A similar observation was reported involving complement-fixing anti-Jk a that had suppressed the reactivity of certain antibodies of the Rh blood groups.[3] We document a case, in which the prozone effect exerted upon anti-D through complement-fixing anti-Le a. As per the best of our knowledge, this is the first case of its kind where the reactivity of a clinically significant anti-D was markedly suppressed by a low titer clinically less significant complement-binding anti-Lewis antibody.


   Materials and Methods Top


Standard serological methods by saline tube/indirect antiglobulin techniques were used in testing throughout. The ABO and RhD blood grouping and antiglobulin reagents were obtained commercially (Span Diagnostic Ltd). The Rh subtyping antisera used were from Ortho Clinical Diagnostics. The Lewis typing was carried out using antibodies identified locally using appropriate controls being run in parallel to the test. Heat inactivation of complement in serum was carried out at 56°C water bath. Immunoglobulin nature of the antibodies was determined using the dithiothreitol (DTT).[4] In brief, equal volume of serum was mixed with 20 mmol DTT in saline and left at room temperature for 15 m. Hemagglutination inhibition test on anti-Le a was performed by mixing antiserum with an equal volume of Le a+ saliva (diluted 1:2 in saline) followed by 20 m incubation and further incubating the test for 60 m after adding group O, Le a+ RBCs. To block the complement activation, ionized calcium was chelated from serum by mixing 1 part of 3.8% trisodium citrate solution to 8 part of serum. Antibody elution from the sensitized RBCs was carried out by heat elution method.


   Results Top


Case detail

The mother, a 26-year-old multipara (4th gravida, 3rd para), with neither having history of blood transfusion nor having hemolytic disease of the newborn (HDNB) to her previous children, delivered her 4th female child at full-term pregnancy. The child weighed 2.3 kg with hemoglobin values of 15.4 g/dL at birth. The child showed a sign of jaundice after 24 h of birth that had progressed to a serum bilirubin level of 27.5 mg/dL (indirect being 24 mg/dL) within the next 48 h. The child was treated with an exchange blood transfusion using 535 ml of homologous blood compatible with her mother's serum by saline, albumin, and antiglobulin methods. The child was grouped as A, RhD+, CDe/cde (R1r); direct antiglobulin test (DAT) was weakly positive. Her serum contained anti-D and anti-Le a, reacting at 37°C by saline, albumin, and antiglobulin methods, was considered as being passively transferred from her mother during intrauterine life. However, eluate from the child's RBCs showed only anti-D reactive by albumin/enzyme/indirect antiglobulin testing (IAT) at 37°C so was considered as the cause of her jaundice. The mother was grouped as A1, RhD-negative (cde/cde, rr), Le (as−b−), and the antibody screen test (AST) on her serum was positive due to the presence of the alloantibody (ies) reacting weakly at 37°C by the albumin/enzyme/IAT methods. Her husband was grouped as A1, RhD positive (CDe/CDe, R1R1), Le (a+b−) and reacted with her serum by the methods employed.

Further investigations showed that the serum reacted with the RBCs in variable strength and at different phases indicating toward multiple specificities. Her serum caused complement-mediated hemolysis of the enzyme premodified red cells having Le a antigens indicating to the anti-Le a being one of the specificities. The presence of anti-D was revealed when the serum reacted with all the ten examples of the enzyme premodified RBCs typed as RhD+, Le (a−) but failed to do so with 11 enzyme-treated RhD-, Le (a−) red cells. Anti-D was also clearly shown upon neutralization of anti-Le a by saliva from individual with Le (a+b−) phenotype. To obviate complement-mediated hemolysis that interfered in expression of anti-D, her serum decomplemented by heating at 56°C or the complement activation pathway was blocked by adding sodium citrate solution to serum to arrest the ionized Ca ++. The results are summarized in [Table 1].
Table 1: The reaction pattern obtained on native and modified with the RBCs of different phenotypes carrying D and Lea antigens

Click here to view


[Table 2] shows the titer values of the two antibodies present in the mother's serum by three different serological techniques. Anti-Le a reacted by saline, antiglobulin, and enzyme techniques with the titer values of 4, 16, and 32, respectively. On the other hand, anti-D reacted by antiglobulin and enzyme techniques with the titer values of 128 and 64, respectively. A prozone effect on anti-D was apparent when the test was carried out by antiglobulin method and involving red cells possessing both D and Le a antigens, whereas it was not seen if the D + red cells had lacked Le a.
Table 2: Showing titer values on antibodies involved

Click here to view



   Discussion Top


Prozone phenomenon, characterized by a weak or no agglutination of the RBCs in undiluted serum having antibody but agglutinated upon dilution of the serum, has long been recognized and considered to be due to an excess of antibody molecules that block and so deprive the antigen sites for agglutinating antibodies. The prozone effect is usually observed with the hyperimmune anti-D or antiglobulin serum.[1]

The prozone effect was reported in the hyperimmune ABO blood group antibodies and was thought to be due to the fixation of the C1 complex resulting through the complement activation.[2],[3] As upon activation of the complement pathway through antigen–antibody interaction on the red cell surface, an accumulation of the C1q, C1r, and C1s forms a large macromolecular complex, with a molecular weight of 700,000, and its deposition on the sensitized red cells may cause a nonspecific physical hindrance at the second stage of hemagglutination by maintaining an intracellular distance greater than that can be bridged by the antibodies.[2] Complement-mediated suppression of hemagglutination was also observed on the reactivity of anti-Rh other than anti-D by the complement-fixing anti-Jk a present in the serum.[5] In the present case, the depressed reactivity of anti-D by coexisting complement-binding anti-Le a deserves the merit to be the first of its kind.

Recently, the role of complement activation as the cause of the prozone phenomenon with respect to the human leukocyte antigen antibody has also been reported.[6],[7] This phenomenon of the complement-mediated hindrance on serological reaction was thought not same as the prozone phenomenon because while the prozone effect can be obviated by diluting the serum, it is not prevented by adding ethylenediaminetetraacetic acid [EDTA] to the sample or inactivating the serum by heating at 56°C.[8]

A positive DAT on the newborn child and the concurrent presence of a high-titer antibody in the mother point toward the diagnosis of the HDNB. In the present case, these two features were present though, to our surprise, the AST on the mother's serum was not that strong as to produce the HDNB. As a matter of fact, the mother's serum showed a variable reaction pattern with different red cells in the panel indicating to a mixture of antibodies to be present. Serum gave gross hemolysis with the papain enzyme-treated red cells carrying Le a antigen indicating to anti-Le a specificity. The anti-Le a sera that fail to lyse untreated test cells almost always lyse enzyme-treated cells.[9] The presence of anti-D was revealed when,

  • The D-positive red cells lacking Le a were used in the test, or
  • The patient's serum mixed with saliva containing Le a substance to neutralize anti-Le a, or
  • If the serum was heat inactivated for complement at 56°C, or
  • The serum was fortified with trisodium citrate, the Ca ++ chelating agent that is essential for complement activation.


As eluate prepared from the child's RBCs showed the presence of the anti-D, hence was incriminated for the disease. However, a possibility of the IgG anti-Le a as contributing factor would still remain open as the anti-Le a coated red cells might have been hemolyzed and might no longer be present in the child's circulation. The cord red cells were found to be efficiently hemolyzed by complement-binding anti-Le a.[10] Spitalnik et al.[11] detected IgG anti-Le a in 12 of the 13 cord sera tested by kinetic enzyme-linked immunosorbent assay indicating that the IgG anti-Le a antibodies do cross the placenta though they do not cause HDNB because of the low levels of Lewis antigens on fetal red cells. However, the mild HDNB due to anti-Le a[12] and anti-Le b[13],[14] has been documented in literature.

The clinical relevance of the complement-mediated prozone phenomenon needs to be kept in mind while using clinical laboratory evidence in evaluating the HDNB, as anti-Lewis is largely complement binding and often found among the pregnant women.[11],[15]


   Conclusion Top


In vitro masking on expression of anti-D in serum of the mother, who delivered a child with HDNB, was evidently exerted by the complement-fixing anti-Le a.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

 
   References Top

1.
van Loghem JJ, Kresner M, Coombs RR, Roberts GF. Observations on a prozone phenomenon encountered in using the anti-globulin sensitization test. Lancet 1950;2:729-32.  Back to cited text no. 1
    
2.
Voak D. Observations on the rare phenomenon of anti-A prozone and the non-specific blocking of haemagglutination due to C1 complement fixation by IgG anti-A antibodies. Vox Sang 1972;22:408-19.  Back to cited text no. 2
[PUBMED]    
3.
Judd WJ, Steiner EA, O'Donnell DB, Oberman HA. Discrepancies in reverse ABO typing due to prozone. How safe is the immediate-spin crossmatch; Transfusion 1988;28:334-8.  Back to cited text no. 3
    
4.
Klein HG, Anstee DJ. Mollison's Blood Transfusion in Clinical Medicine. 11th ed. Oxford, UK: Blackwell Publishing Ltd.; 2005. p. 338.  Back to cited text no. 4
    
5.
Lown JA, Holland PA, Barr AL. Inhibition of serological reactions with enzyme-treated red cells by complement binding alloantibodies. Vox Sang 1984;46:300-5.  Back to cited text no. 5
[PUBMED]    
6.
Weinstock C, Schnaidt M. The complement-mediated prozone effect in the Luminex single-antigen bead assay and its impact on HLA antibody determination in patient sera. Int J Immunogenet 2013;40:171-7.  Back to cited text no. 6
[PUBMED]    
7.
Schwaiger E, Wahrmann M, Bond G, Eskandary F, Böhmig GA. Complement component C3 activation: The leading cause of the prozone phenomenon affecting HLA antibody detection on single-antigen beads. Transplantation 2014;97:1279-85.  Back to cited text no. 7
    
8.
Berth M. Complement interference is not the same as a prozone phenomenon. Am J Transplant 2016;16:1638.  Back to cited text no. 8
[PUBMED]    
9.
Klein HG, Anstee DJ. Mollison's Blood Transfusion in Clinical Medicine. 11th ed. Oxford, UK: Blackwell Publishing Ltd.; 2005. p. 137.  Back to cited text no. 9
    
10.
Cutbush M, Giblett ER, Mollison PL. Demonstration of the phenotype Le (a+b+) in infants and in adults. Br J Haematol 1956;2:210-20.  Back to cited text no. 10
[PUBMED]    
11.
Spitalnik S, Cowles J, Cox MT, Blumberg N. Detection of IgG anti-Lewis (a) antibodies in cord sera by kinetic Elisa. Vox Sang 1985;48:235-8.  Back to cited text no. 11
[PUBMED]    
12.
Carreras Vescio LA, Torres OW, Virgilio OS, Pizzolato M. Mild hemolytic disease of the newborn due to anti-Lewis (a). Vox Sang 1993;64:194-5.  Back to cited text no. 12
[PUBMED]    
13.
Bharucha ZS, Joshi SR, Bhatia HM. Hemolytic disease of the newborn due to anti-Le b. Vox Sang 1981;41:36-9.  Back to cited text no. 13
[PUBMED]    
14.
Reid ME, Ellisor SS. Hemolytic disease of newborn due to anti-Leb b. Vox Sang 1982;42:278.  Back to cited text no. 14
[PUBMED]    
15.
Kissmeyer-Nielsen F. Irregular blood group antibodies in 200,000 individuals. Scand J Haematol 1965;2:331. In: Mollison PL, Engelfriet CP, Contreras M. Blood Transfusion in Clinical Medicine. 10th ed. Oxford, UK: Blackwell Science Ltd.; 1997. p. 138.  Back to cited text no. 15
    

Top
Correspondence Address:
Sanmukh R Joshi
Lok Samarpan Raktadan Kendra, Mini Bazaar, Varachha Road, Surat - 395 006, Gujarat
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0973-6247.214328

Rights and Permissions



 
 
    Tables

  [Table 1], [Table 2]



 

Top
 
  Search

  
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Email Alert *
    Add to My List *
* Registration required (free)  


    Abstract
   Introduction
    Materials and Me...
   Results
   Discussion
   Conclusion
    References
    Article Tables

 Article Access Statistics
    Viewed30    
    Printed2    
    Emailed0    
    PDF Downloaded0    
    Comments [Add]    

Recommend this journal

Association Contact us | Sitemap | Advertise | What's New | Feedback | Copyright and Disclaimer

2006 - Asian Journal of Transfusion Science | Published by Wolters Kluwer - Medknow
Online since 10th November, 2006